We are on a mission to find the first-ever drug to tackle MEF2C deficiency.
Join us.
Rare Bird
Advancing MEF2C Therapeutics
rare bird (noun):
an exceptional person or thing; a rarity
Rare Bird is a U.S.-based organization dedicated to advancing and promulgating research that improves the understanding and development of therapeutics for MEF2C Haploinsufficiency Syndrome (MCHS), a rare neurodevelopmental disease that affects 350 children and young adults worldwide.
funding the future
Our team was the largest single funder of MEF2C-focused therapeutics last year. Email us to join the effort.